Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (533)	3/7/2005 2:14:25 PM
From: Sam Citron	Read Replies (1) of 946

It is however impossible to have an opinion on how likely this is, as long as we have no idea if there was a trend or not towards superiority seen in Stellar 3. This is precisely the issue that Jason Kantor [Hambrecht analyst] was trying to ferret out from Bianco in the very first question on this morning's conference call [now archived: 888-203-1112 code: 5843060]. Bianco stated at the outset of the call that there would be no quantitatitive data released until ASCO and in response all we heard was that Xyotax was overall on the right side of the survival curve from Taxol. [This is based on my notes. It was a bit hard to hear in parts.] Sam

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next